LINACLOTIDE | A209564 | MYLAN PHARMACEUTICALS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Forest Laboratories, LLC et al v. Mylan Pharmaceuticals Inc. 10 patentsANDA 209564linaclotide | D. Del. | 2017-11-30 | Terminated 2018-08-30 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Buchanan Ingersoll & Rooney PC ( on behalf of Synergy P... FDA-2018-P-0884 · 4 docket documents Buchanan Ingersoll & Rooney PC, on behalf of Synergy Pharmaceuticals Inc., filed this citizen petition under 21 C.F.R. § 10.30 requesting that the FDA Commissioner require modification of the approved package insert for Linzess (linaclotide), NDA 202-811, to provide more complete and accessible adve | Other | 2018-02-27 | Denied | Synergy Pharmaceuticals Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.